Treatment experiences of children and adolescents with attention-deficit/hyperactivity disorder

被引:6
|
作者
Leggett, Catherine [1 ]
Hotham, Elizabeth [2 ]
机构
[1] Womens & Childrens Hosp, Dept Pharm, Child Youth & Womens Hlth Serv, Adelaide, SA 5006, Australia
[2] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia
关键词
adolescent; attention-deficit/hyperactivity disorder; child; therapeutics; DEFICIT HYPERACTIVITY DISORDER; ALTERNATIVE THERAPIES; COMPLEMENTARY; ADHD;
D O I
10.1111/j.1440-1754.2011.02013.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: To gain insight into the treatment experiences of children and adolescents diagnosed with attention-deficit/hyperactivity disorder (ADHD). Methods: Convenience sampling was used to recruit eligible parents and carers at paediatric clinics of the Children's, Youth and Women's Health Service to participate in an interview to discuss experiences, using a semi-structured questionnaire. Results: Thirty-five interviews were conducted. Twenty-five subjects had trialled an average of 1.5 interventions prior to receiving an ADHD diagnosis, namely, dietary modifications (46%), behavioural therapy (24%), learning assistance (8%) and natural remedies (8%). Following an ADHD diagnosis, 25 subjects tried an average of 2.8 interventions, most commonly behavioural therapies (48%), expressive therapies (48%) and fish oil (36%). All subjects started psychostimulant medication after receiving an ADHD diagnosis. Despite 52% of parents expressing initial reluctance towards psychostimulants, 97% reported positive experiences with use in terms of schooling, social interaction and family life. Of those being treated with psychostimulants, 22 (73%) were concurrently using other treatments at the time of interview. Conclusions: Few patients use psychostimulant medication in isolation, with the majority of parents using multiple approaches to manage their child's behaviour. Parents tried a variety of therapies before commencing psychostimulant medication, often because of fears regarding psychostimulant safety. Parents were generally happy with the results gained; however adolescents interviewed were less convinced of the benefits of psychostimulants.
引用
收藏
页码:512 / 517
页数:6
相关论文
共 50 条
  • [31] Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents
    Connor, Daniel F.
    Arnsten, Amy F. T.
    Pearson, Geraldine S.
    Greco, Gabriella F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1601 - 1610
  • [32] Prevalence of bipolar disorder in children and adolescents with attention-deficit hyperactivity disorder
    Hassan, Amani
    Agha, Sharifah Shameem
    Langley, Kate
    Thapar, Anita
    BRITISH JOURNAL OF PSYCHIATRY, 2011, 198 (03) : 195 - 198
  • [33] Persistence of Stimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Palli, Swetha R.
    Kamble, Pravin S.
    Chen, Hua
    Aparasu, Rajender R.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (02) : 139 - 148
  • [34] Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder
    Poulton, Alison
    Kwok, Samson
    Nanan, Ralph
    PEDIATRICS, 2008, 122 (04) : 910 - 910
  • [35] Loneliness in Children and Adolescents With and Without Attention-Deficit/Hyperactivity Disorder
    Houghton, Stephen
    Roost, Eileen
    Carroll, Annemaree
    Brandtman, Mark
    JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT, 2015, 37 (01) : 27 - 37
  • [36] The economic impact of Attention-Deficit/Hyperactivity disorder in children and adolescents
    Pelham, William E.
    Foster, E. Michael
    Robb, Jessica A.
    JOURNAL OF PEDIATRIC PSYCHOLOGY, 2007, 32 (06) : 711 - 727
  • [37] Attention-deficit hyperactivity disorder - bipolar comorbidity in children and adolescents
    Masi, Gabriele
    Perugi, Giulio
    Toni, Cristina
    Millepiedi, Stefania
    Mucci, Maria
    Bertini, Nicoletta
    Pfanner, Chiara
    BIPOLAR DISORDERS, 2006, 8 (04) : 373 - 381
  • [38] Sleep quality in children and adolescents with attention-deficit and hyperactivity disorder
    Miniksar, Dilsad Yildiz
    Ozdemir, Mikail
    ARCHIVES DE PEDIATRIE, 2021, 28 (08): : 668 - 676
  • [39] Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents
    Garnock-Jones, Karly P.
    Keating, Gillian M.
    CNS DRUGS, 2010, 24 (01) : 85 - 88
  • [40] The economic impact of attention-deficit/hyperactivity disorder in children and adolescents
    Pelham, William E.
    Foster, E. Michael
    Robb, Jessica A.
    AMBULATORY PEDIATRICS, 2007, 7 (01) : 121 - 131